Session Information
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
IS08 - Industry Symposium Sponsored by Eli Lilly And Company: Personalizing and Optimizing Treatment for Metastatic NSCLC Patients with EGFR Mutations - Is There More We Can Do?
- 05:45 - 06:45
- 9/10/2021
- Location: Industry Symposium Auditorium via Industry Hub
- Not for CME Credit
- Type: Industry Supported Symposium
- Track: N.A.
-
+
IS08.01 - Welcome and Introduction
05:45 - 05:50 | Presenter: Mark A. Socinski
- Abstract
No abstract available for this presentation
-
+
IS08.02 - Is a One Size Fits All Approach Still Appropriate for NSCLC with an EGFR Mutation, Are All Mutations Equal?
05:50 - 06:05 | Presenter: Silvia Novello
- Abstract
No abstract available for this presentation
-
+
IS08.03 - Scientific Rationale for Dual Inhibition of VEGF and EGFR
06:05 - 06:15 | Presenter: Nobuyuki Takakura
- Abstract
No abstract available for this presentation
-
+
IS08.04 - Identifying the Clinical and Disease Characteristics of the High Risk Patient, What Is the Science Telling Us?
06:15 - 06:25 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
IS08.05 - Panel Discussion and Q&A
06:25 - 06:40
- Abstract
No abstract available for this presentation
-
+
IS08.06 - Symposium Closing Remarks
06:40 - 06:45 | Presenter: Mark A. Socinski
- Abstract
No abstract available for this presentation
-
+
IS09 - Industry Symposium Sponsored by Janssen Pharmaceutical Research & Development: Innovations in Lung Cancer Detection and Management of Non-Small Cell Lung Cancer (NSCLC) With Targeted Therapy
- 05:45 - 06:45
- 9/10/2021
- Location: Industry Symposium Auditorium via Industry Hub
- Not for CME Credit
- Type: Industry Supported Symposium
- Track: N.A.
- Moderators:Joshua Sabari
-
+
IS09.01 - Welcome and Introductions
05:45 - 05:50 | Presenter: Joshua Sabari
- Abstract
No abstract available for this presentation
-
+
IS09.02 - EGFR Mutated NSCLC – Progress, Recent Developments, and Unmet Needs
05:50 - 06:05 | Presenter: Ticiana Leal
- Abstract
No abstract available for this presentation
-
+
IS09.03 - Advances in Early Diagnosis, Detection and Intervention of Lung Cancer
06:05 - 06:20 | Presenter: Chris Manley
- Abstract
No abstract available for this presentation
-
+
IS09.04 - Discussion & Q&A
06:20 - 06:45
- Abstract
No abstract available for this presentation
-
+
IS10 - Satellite CME Symposium by Research To Practice: Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer and Validated Targets Beyond EGFR
- 05:45 - 06:45
- 9/10/2021
- Location: Program Auditorium
- CME Accredited by Other Provider
- Type: Satellite CME Symposia
- Track: N.A.
- Moderators:D. Ross Camidge, Justin Gainor, Neil Love, Alexander Drilon
-
+
IS10.01 - MODULE 1: Selection and Sequencing of Therapy for Patients with Non-Small Cell Lung Cancer (NSCLC) and an ALK Rearrangement
05:45 - 06:00
- Abstract
No abstract available for this presentation
-
+
IS10.02 - MODULE 2: Current and Future Directions in the Management of ROS1-Positive NSCLC
06:00 - 06:15
- Abstract
No abstract available for this presentation
-
+
IS10.03 - MODULE 3: Optimal Use of Recently Approved RET Inhibitors in the Care of Patients with RET-Positive NSCLC
06:15 - 06:30
- Abstract
No abstract available for this presentation
-
+
IS10.04 - MODULE 4: Rational Approaches to Targeting MET Abnormalities for Patients with NSCLC
06:30 - 06:45
- Abstract
No abstract available for this presentation
-
+
JIES01 - Joint IASLC – ESTRO Session: Advances in Radiotherapy for Lung Cancer
- 07:00 - 08:00
- 9/10/2021
- Location: Program Auditorium
- Not for CME Credit
- Type: Education Session
- Track: N.A.
- Moderators:Umberto Ricardi, Giorgio Vittorio Scagliotti
-
+
JIES01.01 - RT in Oligometastatic Disease
07:00 - 07:10 | Presenter: Fiona Mary Alison McDonald
- Abstract
No abstract available for this presentation
-
+
JIES01.02 - Radiomics and Radiotherapy: State of the Art and Future Challenges
07:10 - 07:20 | Presenter: Dirk De Ruysscher
- Abstract
Loading... -
+
JIES01.03 - Combining Radiotherapy and Immunotherapy
07:20 - 07:30 | Presenter: Corinne Faivre-Finn
- Abstract
No abstract available for this presentation
-
+
JIES01.04 - Prophylactic Cranial Irradiation in Lung Cancer: Where We Are
07:30 - 07:40 | Presenter: Ben J. Slotman
- Abstract
Loading... -
+
JIES01.05 - Live Discussion with Speakers
07:40 - 08:00
- Abstract
No abstract available for this presentation
-
+
ES01 - Proactive Tobacco and Cancer Control*
- 07:30 - 08:05
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Risk Reduction and Tobacco Control
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Douglas Arenberg, Michael Cummings
-
+
ES01.01 - The Influence of Lung Cancer Provider in Tobacco Control and Policy Advocacy
07:30 - 07:32 | Presenter: Charis Girvalaki
- Abstract
No abstract available for this presentation
-
+
ES01.02 - Setting Clinical Tobacco Cessation Efforts Up for Success
07:32 - 07:34 | Presenter: Joelle Thirsk Fathi
- Abstract
No abstract available for this presentation
-
+
ES01.03 - Integration of Cessation Services in Low Dose CT Screening
07:34 - 07:36 | Presenter: Emily Stone
- Abstract
Loading... -
+
ES01.04 - Examining Health Outcomes in Patients Being Treated for Lung Cancer Who Smoke
07:36 - 07:38 | Presenter: Matt Evison
- Abstract
No abstract available for this presentation
-
+
ES01.05 - Live Discussion with Speakers
07:38 - 08:05
- Abstract
No abstract available for this presentation
-
+
ES02 - Multidisciplinary Collaboration in the Treatment of Oligometastatic Disease*
- 08:15 - 08:50
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Multimodality of Advanced Lung Cancer
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Fiona Mary Alison McDonald, Gerry Hanna
-
+
ES02.01 - Overview of Oligometastatic Disease
08:15 - 08:17 | Presenter: Ross Soo
- Abstract
No abstract available for this presentation
-
+
ES02.02 - Surgical Trials in Oligometastatic Disease
08:17 - 08:19 | Presenter: Nasser Altorki
- Abstract
No abstract available for this presentation
-
+
ES02.03 - Radiation Trials in Oligometastatic Disease: Any Actionable Answers?
08:19 - 08:21 | Presenter: Puneeth Iyengar
- Abstract
No abstract available for this presentation
-
+
ES02.04 - Systemic Therapy Influenced Trials in Oligometastatic Disease
08:21 - 08:23 | Presenter: Paul Leslie Ross Mitchell
- Abstract
Loading... -
+
ES02.05 - Uncertainties and Controversies in Oligometastatic Disease
08:23 - 08:25 | Presenter: Suresh Senan
- Abstract
No abstract available for this presentation
-
+
ES02.06 - Live Discussion with Speakers
08:25 - 08:50
- Abstract
No abstract available for this presentation
-
+
ES03 - Optimizing Survival with Multidisciplinary Collaboration*
- 08:15 - 08:50
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Nursing and Allied Health Professionals
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Morten Quist, Lisa Burgess
-
+
ES03.01 - The Effects of Lung Cancer on Patient's Sexual Functioning: Nursing View
08:15 - 08:17 | Presenter: Somaya Abou-Abdou
- Abstract
No abstract available for this presentation
-
+
ES03.02 - Speech Pathology Management in Lung Cancer
08:17 - 08:19 | Presenter: Jacqui Frowen
- Abstract
No abstract available for this presentation
-
+
ES03.03 - Empowering Patients to Make Change: The Use of Motivational Interviewing
08:19 - 08:21 | Presenter: Ashlee Mulimba
- Abstract
No abstract available for this presentation
-
+
ES03.04 - Multimodal Intervention (Nutrition, Exercise, Pharmacological) for Cancer Cachexia in Lung Cancer
08:21 - 08:23 | Presenter: Nicole Kiss
- Abstract
No abstract available for this presentation
-
+
ES03.05 - Enhanced Recovery After Thoracic Surgery
08:23 - 08:25 | Presenter: TaCharra Woodard
- Abstract
No abstract available for this presentation
-
+
ES03.06 - Live Discussion with Speakers
08:25 - 08:50
- Abstract
No abstract available for this presentation
-
+
ES04 - Antibody–Drug Conjugates: Current Status and Future Perspectives*
- 09:00 - 09:35
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Novel Therapeutics and Targeted Therapies
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Maria Rosario García Campelo, Ana Gelatti
-
+
ES04.01 - Structure and Mechanism of Antibody Drug Conjugates
09:00 - 09:02 | Presenter: Bob T. Li
- Abstract
No abstract available for this presentation
-
+
ES04.02 - Antibody Drug Conjugates for Non-small Cell Lung Cancer
09:02 - 09:04 | Presenter: Hidetoshi Hayashi
- Abstract
Loading... -
+
ES04.03 - Antibody Drug Conjugates for Other Thoracic Tumor Types
09:04 - 09:06 | Presenter: David Planchard
- Abstract
No abstract available for this presentation
-
+
ES04.04 - Antibody Drug Conjugates for Combination Therapy
09:06 - 09:08 | Presenter: Byoung Chul Cho
- Abstract
No abstract available for this presentation
-
+
ES04.05 - Live Discussion with Speakers
09:08 - 09:35
- Abstract
No abstract available for this presentation
-
+
ES05 - A New Era of Treatment and Diagnosis for Mesothelioma and Thymoma*
- 09:00 - 09:35
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Hedy Kindler, Anne Tsao
-
+
ES05.01 - Molecular Markers in Mesothelioma
09:00 - 09:02 | Presenter: Jennifer L. Sauter
- Abstract
No abstract available for this presentation
-
+
ES05.02 - Advances in Immunotherapy in Malignant Pleural Mesothelioma
09:02 - 09:04 | Presenter: Arnaud Scherpereel
- Abstract
No abstract available for this presentation
-
+
ES05.03 - CAR T-cell Therapy in Mesothelioma and Thymic Cancer
09:04 - 09:06 | Presenter: Joachim G.J.V. Aerts
- Abstract
No abstract available for this presentation
-
+
ES05.04 - The Latest Updates in Thymoma
09:06 - 09:08 | Presenter: Meinoshin Okumura
- Abstract
No abstract available for this presentation
-
+
ES05.05 - Live Discussion with Speakers
09:08 - 09:35
- Abstract
No abstract available for this presentation
-
+
ES06 - Immuno-Biology and Novel Immunotherapeutics in Lung Cancer*
- 09:45 - 10:20
- 9/10/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Education Session
- Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Jordi Remon, Lizza Hendriks
-
+
ES06.01 - Task Force in Methodology: Developing New Trials with Immunotherapeutic Agents
09:45 - 09:47 | Presenter: Rosalyn Juergens
- Abstract
No abstract available for this presentation
-
+
ES06.02 - Bi-Specific Agents
09:47 - 09:49 | Presenter: Taofeek Owonikoko
- Abstract
No abstract available for this presentation
-
+
ES06.03 - "Not Just Another irAE" - Identification and Management of Immunotoxicities of Bispecifics and CAR-T
09:49 - 09:51 | Presenter: Melissa Johnson
- Abstract
No abstract available for this presentation
-
+
ES06.04 - Intra-tumoral Immunotherapy
09:51 - 09:53 | Presenter: Stephane Champiat
- Abstract
No abstract available for this presentation
-
+
ES06.05 - Approach to Chemotherapy for Oncogene-driven Cancers: Known Barriers and Future Promise
09:53 - 09:55 | Presenter: Noemi Reguart
- Abstract
No abstract available for this presentation
-
+
ES06.06 - Live Discussion with Speakers
09:55 - 10:20
- Abstract
No abstract available for this presentation
